How can we help to the ophthamologists to accelerate the screening of retinal diseases in order to detect disorders at their early stage?
DreamUp Vision builds an innovative retinal analysis engine based on the state-of-the art machine learning known as deep learning. It performs a quick detection of complicated patterns in retinal images.
Our solutions is a Saas platform which can be used by Healthcare professionals staying in permanent contact with a diabetic patient. They facilitate early diagnosis of the different retinal disorders.
Saas platform and embedded solution linked to a visual recognition system able to distinguish the presence of a retinal abnormality on the basis of a fundus photo.
Former CEO, Co-founder
Co-founder, Strategy advisorNicolas is the co-founder of DreamUp Vision and the founder of DreamQuark. After finishing a PhD in Particle Physics (2013) at CERN (Atlas experiment), CEA Saclay and LPTHE, Nicolas decided to apply what he has learned and developed during his PhD studies to help insurance and healthcare companies to better use their data in order to provide better predictive models, prevention and diagnosis with the help of deep-learning algorithms and created DreamQuark in March 2014. Nicolas is advising DreamUp Vision on the business develoment.
Independent Board DirectorWith 20-year international corporate experience in North America, Europe and Asia, Tram is passionate about market creation. Today Tram helps digital health medtech start-ups or SMEs that want to expand in Europe shape their strategy, land their ideal customers or their next strategic milestone. Rapid results are achieved with her “door- opener” process. Tram Trinh founded VITAnLINK with one mission: instill hands-on & timely execution, grow and build out-of-the-box opportunities for/with the best people in the digital health medtech landscape. Prior to VITAnLINK, she was instrumental in shaping new services within the MedTech & Diagnostics industry. At Johnson&Johnson OCD, she took the responsibility of Project Leader France for the CEO office, then moved to Market Development Director France and to Europe Middle East and Africa Head Marketing Services with 2 J&J Standards of leadership Awards joining also the J&J International "High-Po" Pool. In 2009, she was Welch Allyn General Manager looking after the French speaking countries to create, expand, structure markets & teams including launching the company’s first connected vital signs devices in Europe. Prior to her healthcare journey, she co-structured in 1994 Ernst&Young Audit’s first business in Vietnam & Cambodia before joining the EY Paris office. She also co-founded motion waves start-up. She had been a long time member of the CJD network of French Entrepreneurs and teaching moderator at the CNAM Art et Métiers Innovation Management Program. Tram is one of the founding executive members at Avenir Femmes Santé, a French Not-For-Profit Association for women’s health. She is also a Mentor and Advisory Board Member at key European, Israeli and North American health startup Accelerators and European Patient Associations. She holds an MBA from McGill University Canada, an Executive Management Certificate from Columbia University and an American CPA license from New Hampshire Board of Accounting, US. She is on the Board of the IPEL Ivy Plus European Leaders international think tank and a NextGen member at AmCham France. Tram lives in Paris and loves Tai Chi.
Chief Medical OfficerOphthalmologist at the 15-20 ("Quinze-Vingts") French National Ophtalmic Center in Paris, France. Fellow of the European Board of Ophthalmology, he received the MD degree from Pierre et Marie Curie Paris University in 2013. He is specialized in medical and surgical retinal diseases, trains ophthalmology residents and has participated in several books and scientific papers. He is also the ophtalmology expert of MeltingDoc, the first app which connects French doctors and helps them solve complex medical cases.
Independent Board MemberCo-founder of GA Partners, an independent M&A firm, Armen is also the co-founder of several start-ups, in particular CellProthera, a French biotech company specialized in heart regeneration through injection of autologous hematopoietic stem cells; and Quintesens, a brand of innovative and organic nutritional food products. He is also an early investor and board member of DreamQuark and Wakie.
Co-founderAxel provides DreamUp Vision with his high-quality expertise on Deep Learning and Computer vision expertise. Axel has done his PhD work at the Laboratoire de Physique theorique of the Ecole Normale Superieure of Paris in Theoretical Particle Physics. His analytical and programming skills are an important asset to develop deep learning technics and to study innovative technologies. Axel also develops 3D-graphics for computer games in his free time.
IF YOUR ARE INTERESTED IN JOINING OUR COMPANY AS:
HQ : 74 RUE DU FAUBOURG SAINT ANTOINE 75012 PARIS
OFFICES : 23 AVENUE D'ITALIE, 75013 PARIS